Salem VA Medical Center

The trials here

What the 9 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease3 trials
• Prostate cancer3 trials
• Schizophrenia2 trials
• Heart failure1 trial
• Obesity1 trial
• Type 2 diabetes1 trial

Phase

• Phase 37 trials
• Phase 21 trial

Status

• Active, not recruiting5 trials
• Completed3 trials
• Recruiting1 trial

Lead sponsor

• Boehringer Ingelheim4 trials
• Candel Therapeutics, Inc.2 trials
• Amgen1 trial
• Janssen Research & Development, LLC1 trial
• Prokidney1 trial

Running trials

• Recruiting

  Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  NCT07037459· Phase 3· Amgen· Source

• Active, not recruiting

  EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

  NCT06531824· Phase 3· Boehringer Ingelheim· Source

• Active, not recruiting

  Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

  NCT05099770· Phase 3· Prokidney· Source

• Active, not recruiting

  A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer

  NCT03748641· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)

  NCT02768363· Phase 2· Candel Therapeutics, Inc.· Source

• Active, not recruiting

  Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer

  NCT01436968· Phase 3· Candel Therapeutics, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure1 recruiting
• Obesity1 recruiting

Closed trials

• Completed

  A Prospective Cohort Study to Assess Clinical Effectiveness of an Investigational Digital Therapeutic (CT-155) in Patients With Experiential Negative Symptoms of Schizophrenia

  NCT06791122· Boehringer Ingelheim· Source

• Completed

  Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2)

  NCT04846881· Phase 3· Boehringer Ingelheim· Source

• Completed

  EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)

  NCT03594110· Phase 3· Boehringer Ingelheim· Source